Results 31 to 40 of about 6,810 (223)

Immunoinformatics and Vaccine Development: An Overview.

open access: yesImmunoTargets and therapy, 2020
The use of vaccines have resulted in a remarkable improvement in global health. It has saved several lives, reduced treatment costs and raised the quality of animal and human lives. Current traditional vaccines came empirically with either vague or completely no knowledge of how they modulate our immune system.
Oli,Angus Nnamdi   +7 more
openaire   +5 more sources

Immune checkpoint therapy modeling of PD-1/PD-L1 blockades reveals subtle difference in their response dynamics and potential synergy in combination

open access: yesImmunoInformatics, 2021
Immune checkpoint therapy is one of the most promising immunotherapeutic methods that are likely able to give rise to durable treatment response for various cancer types.
Kamran Kaveh, Feng Fu
doaj   +1 more source

Manganese mediates antiviral effects by driving an ATM -TBK1 phosphorylation signaling pathway

open access: yesFrontiers in Immunology
Ataxia-telangiectasia mutated (ATM) is traditionally recognized as a nuclear kinase involved in DNA damage repair. We were the first to report that ATM also participates in a manganese (Mn)-dependent TBK1 phosphorylation pathway.
Hongyan Sui   +8 more
doaj   +1 more source

SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein

open access: yesImmunoInformatics, 2022
The Omicron (BA.1/B.1.1.529) variant of SARS-CoV-2 harbors an alarming 37 mutations on its spike protein, reducing the efficacy of current COVID-19 vaccines. In this study, we identified CD8+ and CD4+ T cell epitopes from SARS-CoV-2 S protein mutants. To
Simone Parn   +2 more
doaj   +1 more source

Immunoinformatics and tick vaccinology

open access: yesExploration of Immunology, 2023
Immunoinformatics is an emerging area focused on development and applications of methods used to facilitate vaccine development. There is a growing interest in the field of vaccinology centered on the new omic science named ‘vaccinomics’. However, this approach has not succeeded to provide a solution against major infections affecting both animals and ...
Rodrigo Rosario-Cruz   +3 more
openaire   +1 more source

Immunoinformatics and epitope prediction in the age of genomic medicine

open access: yes, 2015
Immunoinformatics involves the application of computational methods to immunological problems. Prediction of B- and T-cell epitopes has long been the focus of immunoinformatics, given the potential translational implications, and many tools have been ...
Kohlbacher, O.   +3 more
core   +1 more source

Image_5_Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches.jpeg

open access: yes, 2022
Coxsackievirus B (CVB) is one of the major viral pathogens of human myocarditis and cardiomyopathy without any effective preventive measures; therefore, it is necessary to develop a safe and efficacious vaccine against CVB.
Fengzhen Deng (14079264)   +14 more
core   +1 more source

Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings

open access: yesImmunoInformatics, 2023
Chimeric antigen receptor (CAR) T-cell based immunotherapy has shown its potential in treating blood cancers, and its application to solid tumors is currently being extensively investigated.
Runpeng Li   +6 more
doaj   +1 more source

Image_4_Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches.jpeg

open access: yes, 2022
Coxsackievirus B (CVB) is one of the major viral pathogens of human myocarditis and cardiomyopathy without any effective preventive measures; therefore, it is necessary to develop a safe and efficacious vaccine against CVB.
Fengzhen Deng (14079264)   +14 more
core   +1 more source

Image_1_Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches.jpg

open access: yes, 2022
Coxsackievirus B (CVB) is one of the major viral pathogens of human myocarditis and cardiomyopathy without any effective preventive measures; therefore, it is necessary to develop a safe and efficacious vaccine against CVB.
Fengzhen Deng (14079264)   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy